Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13668
Country/Region: Mozambique
Year: 2015
Main Partner: Ariel Glaser Pediatric AIDS Healthcare Initiative
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $25,768,800 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $3,602,686
Care: TB/HIV (HVTB) $643,295
Care: Pediatric Care and Support (PDCS) $882,099
Health Systems Strengthening (OHSS) $450,000
Testing: HIV Testing and Counseling (HVCT) $3,294,806
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,543,472
Treatment: Adult Treatment (HTXS) $12,272,236
Treatment: Pediatric Treatment (PDTX) $2,080,206
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 17,500
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 219,293
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 74,087
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 19,737
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 26,315
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 227
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 227
GEND_GBV Number of people receiving post-GBV care 2016 2,271
HRH_PRE By Graduates: Nurses 2016 132
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2016 203
HRH_PRE Sum of Graduates disaggregates 2016 203
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 132,715
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 836,748
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 881
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 11,762
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 2,202
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 11,762
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 881
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 4,702
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 1,321
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 7,060
PMTCT_ARV Sum of New and Current disaggregates 2016 2,202
PMTCT_ARV Sum of New and Current disaggregates 2016 11,762
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 7,861
PMTCT_STAT By: Known positives at entry 2016 255
PMTCT_STAT By: Known positives at entry 2016 3,410
PMTCT_STAT By: Number of new positives identified 2016 626
PMTCT_STAT By: Number of new positives identified 2016 8,352
PMTCT_STAT Number of new ANC and L&D clients 2016 37,199
PMTCT_STAT Number of new ANC and L&D clients 2016 93,993
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 39,068
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 98,686
PMTCT_STAT Sum of Positives Status disaggregates 2016 881
PMTCT_STAT Sum of Positives Status disaggregates 2016 11,762
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 6,281
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 5,652
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 17,500
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 219,293
TX_CURR Age/Sex: <1 Female 2016 1,689
TX_CURR Age/Sex: <1 Female 2016 194
TX_CURR Age/Sex: <1 Male 2016 1,689
TX_CURR Age/Sex: <1 Male 2016 194
TX_CURR Age/Sex: 1-4 Female 2016 3,840
TX_CURR Age/Sex: 1-4 Female 2016 440
TX_CURR Age/Sex: 1-4 Male 2016 3,840
TX_CURR Age/Sex: 1-4 Male 2016 440
TX_CURR Age/Sex: 5-14 Female 2016 2,712
TX_CURR Age/Sex: 5-14 Female 2016 308
TX_CURR Age/Sex: 5-14 Male 2016 2,712
TX_CURR Age/Sex: 5-14 Male 2016 308
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 12,249
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 153,508
TX_CURR Sum of age/sex disaggregates 2016 16,482
TX_CURR Sum of Age/Sex disaggregations 2016 1,884
TX_NEW Aggregated Grouping by Age: <1 Male 2016 638
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2016 638
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 40,338
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 21,721
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 68,317
TX_NEW Pregnancy status 2016 7,060
TX_NEW Sum of Age/Sex disaggregates 2016 2,908
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 62,059
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 24,191
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 31,993
Cross Cutting Budget Categories and Known Amounts Total: $1,088,925
Human Resources for Health $773,720
Motor Vehicles: Purchased $315,205